Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi Biotec Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec

Miltenyi Biotec
Gene expression profiling products
miRNA expression profiling products
a-Hyb™ Hybridization Station
KIR typing
Protein isolation and analysis
navigationHIV/virus isolation
Mitochondria isolation
Transfected cell selection
MACS® Separators and Columns
Genomics services
Miltenyi Biotec
MACS eNewsletter
Subscribe to the
MACS eNewsletter
for regular product information via e-mail.
Miltenyi Biotec
HIV Research
HIV Isolation and Cell Culture
The VitalVirus HIV Isolation Kits have been developed to isolate viable and infectious HIV-1 from clinical samples. Once isolated, the HIV Infectivity Enhancement Reagent enables the efficient and rapid expansion of HIV isolates in PBMC or hematopoeitic cell lines.
VitalVirus HIV Isolation Kits
Research with intact HIV-1 virions from plasma, serum, or other bodily fluids without extensive sample processing

Rapid magnetic virus isolation with μMACS™ VitalVirus HIV Isolation Kit

Viable and infectious HIV-1 for downstream studies such as viral genotyping, viral phenotyping, neutralization studies or development of primary isolates.

The envelope of human immunodeficiency virus 1 (HIV-1) contains not only virus-encoded proteins, but also host cell proteins1, 2, 3. It has been determined that CD44 is the most effective host cell marker for the general labeling and capture of HIV-1 from patient samples and culture-derived virus, independent of the origin of the virus (lymphoid or myeloid cells).4 Accordingly, the μMACS VitalVirus HIV Isolation Kit contains CD44 MicroBeads for magnetic labeling of HIV virions (see figure 1). These MicroBeads are coupled to a monoclonal antibody that recognises the CD44H isoform present on hematopoietic cells.

Gentle magnetic isolation. Once the virions are magnetically labeled with CD44 MicroBeads, MACS® Column Technology enables a very gentle isolation to yield viable and infectious HIV-1 for downstream research applications such as

  • Enrichment of live and infectious HIV-1 (see figure 2) for downstream studies, including neutralization studies, and the development of primary isolates.
  • Enrichment of infectious HIV-1 in the presence of neutralizing antibodies or other uncharacterized HIV serum inhibitors.
  • Enrichment of infectious HIV-1 for drug resistance phenotyping
  • Enrichment and detection of HIV-1 from normal, dilute, and/or difficult samples, for example, cerebral spinal fluid, cervical lavage, or breast milk.
  • Enrichment of HIV-1 for direct RT-PCR and genotyping 5

Optimized PBMC stimulation protocol. The use of the 3x3 Stimulation Protocol for peripheral blood mononuclear cells (PBMCs) in combination with the µMACS™ VitalVirus HIV Isolation Kit greatly increases the success rate of the isolation of infectious HIV-16.

Alternative markers for indirect HIV-1 isolation. It is also possible to isolate virus via other host cell surface molecules that are incorporated into the HIV-1 membrane using biotinylated monoclonal antibodies and the μMACS Streptavidin Kit.4
The special protocol "Isolation of infectious HIV-1", describes the indirect method of magnetic virus isolation for viral compartmentalization studies.
HIV Infectivity Enhancement Reagent
The HIV Infectivity Enhancement Reagent is a unique tool to simplify and accelerate HIV cell culture procedures. A 30 minute coincubation of the viral supernatant and reagent before addition to the target cells is all that is required for the following benefits:

More infected target cells. Up to 100-fold more target cells are infected in the presence of the reagent.
Increase in integration events. Up to 100-fold more proviral copies are inserted into the host cell genome.
Accelerated kinetics of infection. Reduce culture times to viral harvest by 50%.
Increased viral yields. Up to 100-fold more virus is present in the cell culture supernatant.

The HIV Infectivity Enhancement Reagent uses the presence of host proteins in both the virus envelope and the target cells to tether HIV on the surface of target lymphocytes and macrophages 7.
Further information
Isolation of infectious HIV-1
[PDF; 105,6 KB]
MACS&more 8-1 (2004)
[PDF; 1,9 MB]
VitalVirus HIV isolation flyer
[PDF; 118,5 KB]
Isolation of infectious HIV using stimulated PBMCs
[PDF; 162,3 KB]
 
Figure 1
MACS® MicroBeads for HIV-1 isolation bind specifically to the host cell protein CD44, which is incorporated in the virus envelope4.
Figure 2
HIV-1 isolation procedure
Miltenyi Biotec
Toolbox
Customer login
Contact
Newsletter
Help
Share
Print this page
My favorites
Your current favorite list is empty.
Products
μMACS VitalVirus HIV Isolation Kit
- for 20 isolations
Components
- 1 mL CD44 MicroBeads
- 4 mL Equilibration Buffer for protein applications
- 30 mL Virus Wash Buffer
- 6 mL Virus Lysis Buffer
- 20 μ Columns
Download datasheet
130-092-805
Qty.:
 

μMACS VitalVirus HIV Isolation Starting Kit
- for 20 isolations
Components
- 1 μMACS VitalVirus HIV Isolation Kit
- 1 μMACS Separator
- 1 MACS MultiStand
Download datasheet
130-092-833
Qty.:
 

MultiMACS VitalVirus HIV Isolation Kit (12×8)
- for 96 isolations
Components
- 5×1 mL CD44 MicroBeads
- 5×4 mL Equilibration Buffer for protein applications
- 5×30 mL Virus Wash Buffer
- 5×6 mL Virus Lysis Buffer
- 12 Multi-8 Columns
- 1 MultiColumn Frame
- 1 Microtiter Plate, U-bottom
- 1 Deep Well Block, 2.5 mL
Download datasheet
130-092-806
Qty.:
 

MultiMACS VitalVirus HIV Isolation Kit (4×96)
- for 384 isolations
Components
- 4× reagents of (12×8) MultiMACS VitalVirus HIV Isolation Kit
- 4 Multi-96 Columns
- 4 Deep Well Blocks, 2.5 mL
- 4 Microtiter Plates, U-bottom
Download datasheet
130-092-807
Qty.:
 

HIV Infectivity Enhancement Reagent
- 20 HIV infections
Components
- 1 mL HIV Infectivity Enhancement Reagent
Download datasheet
130-095-093
Qty.:
 

μMACS Streptavidin Kit
- for 20 isolations
Components
- 2 mL μMACS Streptavidin MicroBeads
- 4 mL Equilibration Buffer for nucleic acids applications
- 4 mL Equilibration Buffer for protein applications
- 20 μ Columns
Download datasheet
130-074-101
Qty.:
 

μMACS Streptavidin Starting Kit
- for 20 isolations
Components
- 1 μMACS Streptavidin Kit
- 1 μMACS Separator
- 1 MACS MultiStand
130-091-287
Qty.:
 

Related products
MACS® Cell Separation Reagents for indirect magnetic labeling
References
1. Tremblay et al. (1998) Immunol. Today 19: 346–351.
2. Ott (1997) Rev. Med. Virol. 7: 167–180.
3. Lawn et al. (2000) J. Virol. 74: 139–145.
4. Lupo and Butera (2004) MACS&more 8(1): 16–19.
5. Piantadosi et al. (2009) J. Virol. 83: 7805-7814
6. Prado et al. (2010) J. Virol. 84(1): 492-502
7. Terry et al. (2009) Virology 388: 294-304
Miltenyi Biotec
© 1999 - 2010 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website